A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

Livnat Jerby‐Arnon, Parin Shah, Michael S. Cuoco, Christopher Rodman, Mei-Ju Su, Johannes C. Melms, Rachel L. Leeson, Abhay Kanodia, Shaolin Mei, Jia‐Ren Lin, Shu Wang, Bokang Rabasha, David Liu, Gao Zhang, Claire Margolais, Orr Ashenberg, Patrick Alexander Ott, Elizabeth Iannotti Buchbinder, Rizwan Haq, Frank Stephen Hodi, Genevieve Marie Boland, Ryan Joseph Sullivan, Dennie Tompers Frederick, Benchun Miao, Tabea O. C. Moll, and 27 more

View at source ↗PDF ↗Article1,428 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1016/j.cell.2018.09.006
Published
Nov 1, 2018
Venue
Cell
DOI
10.1016/j.cell.2018.09.006
PubMed
30388455
Categories
Cancer Immunotherapy and Biomarkers
Provenance
openalex

Topics